4,4-dioxo-5,6-dihydro-[1,4,3]oxathiazines, a novel class of 11 beta-hsd1 inhibitors for the treatment of diabetes Deposition Author(s): Engel, C.K. , Loenze, P. , Schimanski-Breves, S. , Von Der Heyden, C.
Date: 2013-04-05 Method: X-RAY DIFFRACTION Resolution: 1.96 Å Organism(s): Homo Sapiens Sequences Data: 4K1L_A , 4K1L_B , 4K1L_C , 4K1L_D